Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
1
10/10/2018
Major Revision of manuscript ID BMJ.2018.045372
Dear Doctor Cook,
Thank you for giving us the opportunity to resubmit a new version of our manuscript entitled
"The role of diet in the prevention of type 2 diabetes: An umbrella review of meta-analyses of
prospective studies” with the ID BMJ.2018.045372.
We would like to thank the experts for their constructive comments and suggestions. Please
find below the point-by-point response to the comments of the reviewers. We have
incorporated their comments and suggestions that were raised. Please also find the new
version of our manuscript. All changes to the originally submitted version have been
highlighted in yellow color. In this letter, the changes made refer to the marked version of the
manuscript. In addition, we have uploaded a clear version of the manuscript.
We hope that the revised version is suitable for publication in BMJ.
Sincerely,
Manuela Neuenschwander and
Sabrina Schlesinger
Dr. Sophie Cook UK research editor, BMJ [email protected]
Manuela Neuenschwander Sabrina Schlesinger (PhD) Institute for Biometrics and Epidemiology German Diabetes Center (DDZ) Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf Auf´m Hennekamp 65 40225 Düsseldorf, Germany Tel.: +49-(0)-211-33-82-415 [email protected]
2
Detailed comments from the meeting:
*Our statistician had many concerns about this paper and has provided a detailed report
below.
Response: We thank Professor Riley for his constructive feedback. We apologize for the
misunderstanding about the level of data pooling. To clarify, we did not summarize multiple
meta-analyses. For each exposure we chose the one meta-analysis that included the largest
numbers of studies and study participants, which was usually the most recent one. Our
umbrella review was conducted as it has been done in the past (e.g. Poole BMJ 2017, PMID:
29167102; Kalliala BMJ 2017, PMID: 29074629; Kyrgiou BMJ 2017, PMID: 28246088;
Tsilidis BMJ 2015, PMID: 25555821). Umbrella reviews systematically search, organise, and
evaluate existing evidence from previous meta-analyses on exposures and health outcomes.
For clarification, we have revised the contents of description of the methods, including the
study design. We addressed the further comments according to Professor Riley‘s feedback.
The detailed information are shown in the responses to Professor Riley‘s comments.
*Such a big umbrella review makes it hard to get to grips with what it actually means given
that it covers such broad issues and becomes quite detached from the primary studies. This
has the potential to lose the thread of what has gone on in the original studies. For example
what variables have been considered?
Response: We believe it is a strength of our umbrella review that it provides such a
comprehensive overview of any existing evidence regarding dietary factors and incidence of
T2D, especially since there is such a large body of research available. By giving such a
broad overview and by evaluating the quality of evidence, internal consistencies or
inconsistencies can be examined and relevant research directions can be identified. Since
we included only meta-analyses of prospective studies we are aware that information of
primary studies, like confounding factors, cannot be ignored. However, to consider this
comment, we went back to all primary studies (n=277) and checked the methods of
adjustment and the confounders which were included in the primary studies, and included
more detailed information about this. Please see our point-by-point answers to comment 4 by
Doctor Merino and to comments 2, 3 and 4 by Professor Riley for detailed information on
changes made.
*The editors thought it would be hard to replicate what the authors had done to get to this
point and the methods section lacks clarity.
3
Response: We thank the editors for bringing this lack of clarity to our attention. We added
more information to the methods section and clarified questions raised about the methods.
Please see our point-by-point answers to comments 3a and 3b by Doctor Merino and
comments 6, 7, 8 and 16 by Professor Riley for more details on changes made.
*The abstract contains a small selection of results, but how were these chosen from the
many findings?
Response: In order to systematically summarize the most important findings and to keep the
abstract short and clear, we particularly emphasized the findings with high quality of
evidence (see comment 2 by Professor Hu).
*We noted that some of these findings are confirmatory and struggled to appreciate what is
new here, this could be better explained for the general reader.
Response: An umbrella review is a useful tool to summarize evidence of published
systematic reviews and meta-analyses (Ioannidis J.P.A, CMAJ 2009). Our umbrella review
includes a wide spectrum of exposures as it has not been done in the past. What we added
to this existing evidence is the evaluation of the methodological quality and quality of
evidence of the meta-analyses. Therefore, internal consistencies and inconsistencies were
uncovered and relevant research directions could be identified. We added this explanation to
our discussion.
*The editors had concerns about the inclusion of both RCTS and observational studies and
feel the pitfalls of this approach needs to be better considered.
Response: We thank the editors for raising this point. According to this comment we now
focus only on observational studies and excluded RCTs (see comment 1, Reviewer 2,
Professor Hu).
Reviewer 1, Doctor Jordi Merino
Comment 1: There are significant inconsistencies between original data reported in included
meta-analysis and extracted data (Supplementary Tables 3,4,5,6). For example, Imamura F,
et al. BMJ 2015 conducted a systematic review and meta-analysis to examine the
4
prospective associations between consumption of sugar sweetened beverages, artificially
sweetened beverages, and fruit juice with T2D. The original study included data extracted
from 17 cohorts (38 253 cases/10 126 754 person years). Higher consumption of sugar
sweetened beverages was associated with a greater incidence of T2D, by 18% per one
serving/day (95%CI: 9- 28, I2 for heterogeneity=89%). Supplementary Table 4 shows that 14
studies were included and the RR per one s/d of sugar sweetened beverages was 1.28
(95%CI 1.12-1.46). Similar inconsistences have been detected in Lee & Park, et al. 2017
Nutrients or Saneei, et al. Public Health Nutrition 2017 (or 2016).
Response: Thank you for raising our attention to this. We checked the extracted data
accordingly and would like to explain the inconsistencies. As for Imamura et al. (BMJ 2015),
the model without adjustment for adiposity and within-person variation included 17 cohorts
and yielded a summary relative risk of 1.18 (1.09 to 1.28). Since we always extracted the
maximally adjusted relative risk, we extracted the data from the model which adjusted for
adiposity and within person variation, which yielded a summary relative risk (95% CI) of 1.28
(1.12 to 1.46) in the published meta-analysis. For this model 14 cohorts with RR and their
95%-CI were available for our recalculation, which resulted in a summary relative risk (95%
CI) of 1.26 (1.11 to 1.43). The small difference in the risk estimates explained by rounding
differences in the recalculations.
As for Lee & Park (Nutrients 2017) the reported summary relative risk (95% CI) of 0.73 (0.61,
0.87) included results from cross-sectional and prospective cohort studies. Since we only
included meta-analyses of prospective cohort studies, we extracted the summary relative risk
(95% CI) of a subgroup analysis (Table 1), which only included prospective cohort studies
(RR (95% CI): 0.64 (0.57, 0.74)).
As for Saneei, et al. (Public Health Nutrition 2017), the number of included studies and the
effect estimate differs slightly between the publication and our umbrella review, because they
counted the same cohort twice (men and women), which we first combined using fixed effect
methods, as described in the methods section.
Comment 2: Literature search was conducted in Medline and Web of Science. Examining
other sources of information such as Embase or Cochrane Database of Systematic Reviews
would be relevant for this umbrella review. In addition, it seems that relevant systematic
reviews and meta-analysis have not been included in this manuscript and are not listed as
excluded studies. Hu EA, et al (BMJ 2012). White rice consumption and risk of type 2
diabetes: meta-analysis and systematic review.
5
Response: We thank Dr. Merino for this comment. We conducted an additional search on
Embase up to August 17th 2018. 3631 publications were identified in this search, including
three new relevant published meta-analyses: one on potatoes (Schwingshackl et al,
European Journal of Nutrition, 2018), one on polyphenols (Rienks et al, American Journal of
Clinical Nutrition, 2018) and one on protein and types of protein (Zhao et al, European
Journal of Nutrition, 2017), which replaced the previously included meta-analyses on this
exposure. The flow chart (Supplementary Figure 1) and the list of excluded studies
(Supplementary Table 2) have been adapted accordingly. Changes in the results section
have been highlighted throughout the manuscript. In addition, the reviewer is correct. We
missed to list the meta-analysis by Hu EA, et al (BMJ 2012). We apologize for the mistake
and thank you for raising our attention to this. We now added the reference to the list of
excluded studies (Supplementary Table 2).
Page 5, line 123ff: The systematic literature search was conducted in Pubmed, Web of
Science and Embase until August 2018 for meta-analyses of observational studies
investigating the association between diet and T2D, using a predefined search strategy
(Supplementary Table 1).
Page 10, line 255f: Of the 11’413 publications initially identified, we finally selected 53
published meta-analyses including 153 SHRs (Supplementary Figure 1).
Page 10, line 260ff: We found meta-analyses on the following exposures: [S], potatoes and
types of potatoes44, [S] total protein and types of protein59, [S] polyphenols and subgroups
of polyphenols73 [S].
Comment 3a: A better description of exposure variables in the methods section would be
desirable.
Response: Thank you for this comment. We added a more detailed description of the
exposure variables to the methods section.
Page 6, line 131ff: Studies were included if they met the following criteria: (1) Meta-analysis
of observational prospective cohort studies in adult populations with multivariable adjusted
summary risk estimates, (2) considering the incidence of T2D as outcome, (3) investigating
the association of different dietary factors assessed by established dietary assessment
6
instruments such as food frequency questionnaires, diet history, 24h dietary recalls, and
dietary records with risk incidence for T2D. Eligible dietary factors included:
• Dietary behaviours/diet quality indices, including dietary patterns as combinations of
nutrients, foods and beverages. Examples are breakfast skipping for dietary behaviours,
glycemic index (GI), glycemic load (GL) or potential renal acid load (PRAL) for dietary
quality indices, Healthy Eating Index (HEI), Dietary Approaches to Stop Hypertension
(DASH), Mediterranean Diet or vegetarian diet for a priori dietary patterns, and the
application of principal component analysis, factor analysis or reduced rank regression for
exploratory-derived dietary patterns.
• Food groups, foods and beverages, including dairy products, eggs, meat, fish, fats (e.g.
butter) and oils, potatoes, whole-grain, grains, cereals rice, legumes, nuts, vegetables,
fruit, tea, coffee, sugar-sweetened and alcoholic beverages.
• Macronutrients (carbohydrates, fats, protein), micronutrients (vitamins, minerals), fibre
and polyphenols.
Comment 3b: I am wondering whether it makes sense to report estimated effect sizes for
exposures that only include data from one single meta-analysis. To my understanding,
umbrella meta-analyses are useful for aggregating findings from several meta-analyses that
address the same question. Regarding to this, if the exposure of interest is overall dietary
pattern quality, it would make more sense to combine results from different meta-analysis
despite these meta-analyses used different methods to define dietary quality (i.e., HEI, AHEI,
MedDiet, DASH).
Response: We thank Dr Merino for raising these questions. Compared to systematic reviews
and meta-analyses that examine one exposure (or one outcome), umbrella reviews are
useful tools to provide an overview of multiple systematic reviews and/or meta-analyses on
several exposures (or several outcomes) (Ioannidis J.P.A, CMAJ, 2009). For most of our
exposures more than one meta-analysis was identified. However, more recent meta-
analyses usually include the same studies with an update of one or two additional primary
studies. To avoid the inclusion of duplicate reports, we chose the meta-analysis providing the
largest number of primary studies and/or the largest number of cases as it has been done in
previously published umbrella reviews (Tsilidis et al, BMJ, 2014; Kyrgiou et al, BMJ 2017;
Poole et al, BMJ 2017). For clarification we added a sentence to the methods section.
In addition, the dietary pattern scores were generated by the inclusion of similar, but also
different components of diet. For example, a component of the Mediterranean diet is a high
intake of monounsaturated fatty acids (mainly through the consumption of olive oil), while
other dietary patterns rather focus on the intake of saturated fatty acids and total fat (HEI,
7
HEI-2005), the intake of polyunsaturated fatty acids (AHEI-2010), or the ratio between
polyunsaturated fatty acids and saturated fatty acids (HEI-2010, AHEI) (Koloverou et al,
Metabolism Clinical and Experimental, 2014; Schwingshackl et al, Journal of the Academy of
Nutrition and Dietetics, 2015). Another example is red and processed meat, which is only
included in the DASH-, AHEI and AHEI-2010-score, while the other scores include meat as a
total (Schwingshackl et al, Journal of the Academy of Nutrition and Dietetics, 2015).
We fully agree with Doctor Merino that an overall dietary pattern quality that combines
different aspects of the single patterns would be of high interest regarding incidence of T2D.
Unfortunately, we do not believe that it is meaningful to combine these findings on the level
of an umbrella review. However, this could be an objective for future primary studies. We
thus added this point to our discussion.
Methods: Page 6, line 153ff: If more than one published meta-analysis on the same
association was identified, we chose only one meta-analysis for each exposure to avoid the
inclusion of duplicate studies. In that case, we included the one with the largest number of
primary studies. [S]
Discussion: Page 26, line 700ff: To account for the full spectrum of the association between
diet and T2D, future studies could investigate a dietary score, including all important aspects
of a healthy diet that have been identified to play a role in the risk of T2D. This approach
might be more predictive of T2D risk than the investigation of single foods and nutrients146.
Comment 3c: The number of meta-analysis included for each exposure would be very
informative as well as the proportion of heterogeneity explained by study size.
Response: Since we included one meta-analysis per exposure, we provide information on
the number of included primary studies in the meta-analysis for each exposure.
For clarification we changed the titles for the respective columns in Figures 1-4 and
Supplemental Table 3 from „number of studies“ to „number of primary studies“.
Heterogeneity was assessed using tau2 and 95%-prediction intervals and are shown in
Supplemental Table 3 and described in the results section.
Page 9, line 237ff: However, I2 is dependent on the study size (it increases with increasing
study size). Therefore, we additionally calculated τ2, which is independent of study size and
describes between study-variability of the risk estimates20. In addition, we used the two-
sigma rule (θ�± 2τ) to calculate the interval where 95% of the primary HRs lie within to
further evaluate the dispersion around the SHR. Finally, we calculated 95%-prediction
8
intervals (95%-PIs) which also account for heterogeneity and show the range in which the
effect estimates of future studies will lie with 95% certainty20.
Comment 4: Are included studies restricted to European descent individuals? In addition,
average age and sex of included studies should be presented to investigate whether
combined estimates are modified by demographic characteristics.
Response: Thank you for raising our attention to this lack of clarity. The included studies are
not restricted to European descent individuals. We agree, that age and sex are important
confounding factors to be considered. However, more than 90% of the studies adjusted for
these factors. This information is now provided in more detail in the description of the
included meta-analyses. However, it was beyond the scope of this umbrella review to
conduct subgroup analyses. We added a statement to the limitations section.
Results: Page 11, line 294f: All published meta-analyses included primary studies from the
US, Europe and Asia/Australia.
Results: Page 12, line 297ff: Almost all of the primary studies (90%) adjusted for age and
sex, 87% for smoking, 86% for BMI and physical activity, respectively, 67% for total energy
intake, 65% for alcohol intake, 60% for other dietary factors or cardiovascular risk factors
(e.g. Hypertension), respectively, and 52% for family history of diabetes.
Discussion: Page 28, line 748ff: Third, we did not explore subgroup analysis (e.g. by sex,
geographic locations, adjustment factors like BMI) or sensitivity analysis (e.g. exclusion of
studies at high risk of bias).
Comment 5: Given the relevance of alcohol intake on health outcomes, I would suggest to
provide evidence on the association between alcohol intake and T2D risk.
Response: We thank Dr. Merino for this suggestion. We have added information on the
available evidence on alcohol intake and T2D (meta-analysis for total alcohol intake: Li et al,
American Journal of Clinical Nutrition, 2016 and meta-analysis for wine, beer and spirits:
Huang et al, Journal of Diabetes Investigation, 2017). The information are shown in Figure 3
and Supplemental Table 3.
Page 10, line 260ff: We found meta-analyses on the following exposures: [S], as well as
total alcohol75, wine, beer and spirits76.
9
Comment 6: Patient involvement statement is missing.
Response: We added a patient involvement statement.
Page 32, line 875f: Patient involvement statement: not required, since no individual patient
data was used in this study
Reviewer 2, Professor Frank Hu
Comment 1: The authors mixed data from prospective cohort studies and RCTs. Because
the evaluation of study quality and data interpretation are different between the two types of
studies. it would be helpful to conduct separate reviews for them. Of note, several RCTs
included in the review analyzed T2D as a secondary outcome rather than a primary outcome.
Response: We thank Professor Hu for raising this important issue. We agree and excluded
RCTs from our review. Consequently, the exposures niacin and selenium were excluded.
Comment 2: In the abstract, the authors emphasized the findings for whole grains, cereal
fiber, red meat, processed meats, and SSBs. However, other findings such as healthy eating
patterns and coffee consumption are also very robust and the quality of the evidence is
similar.
Response: Thank you for this comment. The evidence for the association between a healthy
dietary pattern and coffee consumption with incidence of T2D was graded as moderate. This
was also the case for 31 other associations (s. Table 1). In order to systematically
summarize the most important findings and to keep the abstract short and clear, we
particularly emphasized the findings with high quality of evidence.
Comment 3: The data on fruit juices and T2D risk are confusing. There are several items on
fruit juices (100% fruit juices, fruit juices, and fruit juices with added sugars). It is unclear
how these items were differentiated in the original studies.
Response: We thank Professor Hu for making this point. We added a description of these
items in the footnote of Figure 2b.
10
Figure 2b, Footnote: **Total fruit juice = fruit juices with added sugar and without added
sugar; 100% fruit juice = fruit juice without added sugar; sugar-sweetened fruit juice = fruit
juice with added sugar; fruit juice, not specified = type of fruit juice (with or without added
sugar) was not specified in these studies
Comment 4: The authors indicated that there was no significant association between nut
consumption and risk of T2D. However, previous meta-analyses on this topic examined this
association with and without adjustment for BMI. The association was significant before BMI
adjustment. One interpretation is that part of the association between nut consumption and
risk of T2D was mediated through body weight. It is important for the authors to capture
nuances of these associations.
Response: In our umbrella review, we included maximally adjusted SHRs for the association
between nut intake and T2D. All included primary studies adjusted for BMI. To capture the
nuances of this association, we added a statement to our manuscript in which we discussed
different results of two meta-analyses regarding nut consumption and incidence of T2D. In
addition, we have added a statement to the limitation section, that we did not explore
differences in subgroups.
Page 20, line 536ff: [S] This is mostly in accordance with our findings with the exception of
the beneficial association of nuts and the harmful association of unprocessed red meat with
incidence of T2D. Disagreements could be explained by the inclusion of different primary
studies. While Micha et al included a meta-analysis with both, RCTs and observational
studies, our report only focused on observational studies90. In addition, the meta-analysis of
Micha et al. missed one primary study, that reported an increased incidence of T2D for
higher intake of nut intake and T2D91, which resulted in a decreased but not statistically
significant summary estimate in our report.
Page 28, line 748ff: Third, we did not explore subgroup analysis (e.g. by sex, geographic
locations, adjustment factors like BMI) or sensitivity analysis (e.g. exclusion of studies at high
risk of bias). [S] Additionally, BMI has been shown to be an influencing factor in the
association between nut intake and incidence of T2D, with an inverse association before and
a null association after adjustment for BMI. In subgroup analysis a reduction in incidence of
T2D was observed for participants with BMI ≥25 kg/m2, no association was shown for
participants with BMI <25 kg/m2 149. However, this was beyond the scope of this umbrella
review, and future reports could explore these more in detail.
11
Comment 5: In terms of omega-6 fatty acids, the authors should focus on linoleic acid, which
is the main type of omega-6. A recent pooled analysis found a robust inverse association
between LA biomarker and incident T2D (Lancet Diabetes Endocrinol. 2017 Dec;5(12):965-
974. doi: 10.1016/S2213-8587(17)30307-8. Epub 2017 Oct 12). This study should be
included.
Response: Thank you for this reference. In our umbrella review, we included only exposures
on dietary intakes rather than biomarkers, and thus, this report did not meet the inclusion
criteria. We added this to our limitations.
Page 29, line 773ff: Sixth, it was beyond the scope of this umbrella review to include
exposures of biomarkers. However, the measurement of certain exposures, e.g. fatty acids,
may lead to bias60 and more specific information on long-term intake may be obtained from
biomarkers151 152, and thus may add to current evidence.
Comment 6: Regarding fish/long-chain omega-3 fatty acids, previous meta-analyses have
found ethnic/racial/geographic differences. Studies conducted in Asian populations tend to
find an inverse association, whereas studies in North America tends to find a slight positive
association. Therefore, the overall association would be null when studies from Asian and
North American cohorts were combined.
Response: We thank Professor Hu for raising this important issue. While it is a valid point, it
is beyond the scope of an umbrella review to conduct subgroup analyses or report subgroup
results. However, we added this to our limitations section.
Page 28, line 748ff: Third, we did not explore subgroup analysis (e.g. by sex, geographic
locations, adjustment factors like BMI) or sensitivity analysis (e.g. exclusion of studies at high
risk of bias). For example, for total omega-3 fatty acids differences between US,
Australian/Asian and European have been shown, with an increased incidence of T2D in US
populations, no association for European countries and an inverse association in Asian
populations148. [S] However, this was beyond the scope of this umbrella review, and future
reports could explore these more in detail.
Comment 7: This review found a positive association between consumption of artificially
sweetened beverages and risk of T2D. This association needs to be interpreted with caution
because of the reverse causation problem. Typically the association was attenuated after
12
adjustment for baseline BMI and metabolic diseases. The authors should include meta-
analyses results with and without adjustment for these variables.
Response: Thank you for making this point. In our umbrella review we show the maximally
adjusted summary risk estimate for each exposure. In their meta-analysis, Imamura et al
(BMJ, 2015) made an effort to account for the reverse causation problem by adjusting for
adiposity and within person variation. The adjustment for adiposity and within person
variation did not alter the results significantly for artificially sweetened beverages (SRR (95%
CI) without adjustment for adiposity and within person variation: 1.25 (1.18 to 1.33) vs. SRR
(95 %) with adjustment for adiposity and within person variation: 1.29 (1.08 to 1.54)).
However, residual confounding cannot be ruled out. We added a statement to our
discussion. Furthermore, as mentioned in the response to comment 6, we added to our
limitations section that it is beyond the scope of this umbrella review to report results on
subgroups (e.g. adjusting and not-adjusting for obesity).
Page 21, line 560ff: [S] Nevertheless, residual confounding cannot be ruled out, perhaps
particularly in the analysis of artificially sweetened beverages where obese persons may
have switched from sugar-sweetened beverages to artificially sweetened beverages to lose
weight. This might explain the association observed before adjustment for BMI and the
attenuation of the association with BMI adjustment56.
Page 28, line 748ff: Third, we did not explore subgroup analysis (e.g. by sex, geographic
locations, adjustment factors like BMI) or sensitivity analysis (e.g. exclusion of studies at high
risk of bias).
Reviewer 3, Professor Rob M. van Dam
General comments:
Comment 1: The Nutrigrade assessment of the quality of evidence for different dietary
factors is of key importance for the conclusions of the paper, but scoring for different dietary
factors for different components of Nutrigrade is not shown. This makes the methodology
difficult to replicate; for example why coffee consumption receives a lower score than red
meat consumption cannot readily be assessed based on the presented data. More
information on this scoring is essential for the transparency of this review.
13
Response: Thank you for making this important point. To increase transparency we added a
table showing the scoring for the different components of NutriGrade for each exposure (see
Supplementary Table 5).
Comment 2: Earlier systematic reviews on dietary factors and diabetes risk have been
published last year (Schwingshackl L, Hoffmann G, Lampousi AM, Knüppel S, Iqbal K,
Schwedhelm C, Bechthold A, Schlesinger S, Boeing H. Food groups and risk of type 2
diabetes mellitus: a systematic review and meta-analysis of prospective studies. Eur J
Epidemiol. 2017 May;32(5):363-375. Micha R, Shulkin ML, Peñalvo JL, Khatibzadeh S,
Singh GM, Rao M, Fahimi S, Powles J, Mozaffarian D. Etiologic effects and optimal intakes
of foods and nutrients for risk of cardiovascular diseases and diabetes: Systematic reviews
and meta-analyses from the Nutrition and Chronic Diseases Expert Group (NutriCoDE).
PLoS One. 2017 Apr 27;12(4):e0175149). The authors cite these papers, but should provide
some more discussion on the existing evidence and what this study adds to the Introduction
section. The current paper does consider a wider range of dietary factors that these previous
efforts.
Response: We thank Professor van Dam for this comment. We added some more discussion
of these papers to the introduction and the discussion.
Introduction: Page 4, line 95ff: Recent reports summarized evidence for selected dietary
factors regarding prevention of T2D9-11. Strong evidence was observed for a decreased
incidence of T2D for higher consumption of whole grains10 11 and a higher adherence to a
healthy dietary pattern10 as well as an increased incidence of T2D for higher intake of total
red meat11, processed meat10 11 and sugar sweetened beverages (SSB)10 11. Micha et al
summarized findings with probable or convincing evidence and found a higher incidence of
T2D for low intake of whole grain, yogurt, nuts/seeds and dietary fibre as well as for high
consumption of unprocessed red meat, processed meat, foods with a high glycemic load
(GL) and SSB9. However, none of these studies focuses on any existing evidence between
dietary factors (including a wide range of dietary factors such as dietary behaviours/diet
quality indices, food groups, foods and beverages, alcoholic beverages as well as macro-
and micronutrients) and incidence of T2D.
Discussion: Page 20, line 533ff: Micha et al. evaluated the evidence between dietary factors
and T2D. They found probable or convincing evidence for an association between low
consumption of nuts, whole grain and dietary fibre, as well as high consumption of
unprocessed red meat, processed red meat and foods with high glycaemic load and the
14
incidence of T2D9. This is mostly in accordance with our findings with the exception of the
beneficial association of nuts and the harmful association of unprocessed red meat with
incidence of T2D. [S]
Comment 3: The main review does not include evidence from trials of dietary factors with
measures of glucose homeostasis as an outcome. This is an important source of evidence,
but it is understood this is difficult to include in the main review. However, the authors should
provide a more balance overview of the evidence from trials of intermediary outcomes in the
Discussion section. Currently, the authors do discuss this for the foods with high quality
evidence, but do not highlight any trials that do not support effects. For eg whole grains there
are several trials that do not show any impact on markers of glucose homeostasis.
Response: Thank you for this comment. We added trials on intermediary outcomes to our
discussion.
Page 21, line 573ff: A recent meta-analysis of randomized controlled trials (RCTs) showed
acute beneficial effects for an intervention with increased whole grain consumption compared
to control meals, including mainly white wheat bread, on postprandial glucose and insulin
response106, which reduces pancreas exhaustion107 108. However, in medium and long-term
RCTs intervention of increased whole grain consumption had no effect on fasting glucose,
fasting insulin and insulin resistance compared to the control diet. Nevertheless, when RCTs
with people at higher risk for T2D were excluded, fasting glucose was lower in the
intervention group compared to the control group106.
Page 23, line 617ff: However, beverages high in fructose or isomaltulose, which is a slowly
absorbable disaccharide used in sports drinks, have a lower GI132. An RCT compared two
intervention groups consuming 20% of their energy requirement in form of beverages
sweetened with isomaltulose (low GI) and maltodextrin (high GI). The insulin response was
lower and insulin sensitivity better preserved in the group consuming beverages with low GI
compared to the group consuming beverages with high GI132. However, fructose that may be
contained in these beverages increases hepatic lipogenesis and insulin resistance133.
Additionally, an RCT comparing interventions of 4 servings/d of SSB, fructose-sweetened
and aspartame-sweetened beverages for eight days, ad lipitum energy intake was
significantly increased in the SSB and fructose-sweetened beverages group compared to the
aspartame-sweetened beverages group, with no difference between the first two groups.
However, since all groups received the same standard diet, which they consumed ad lipitum,
15
the excess calories in the SSB and fructose-sweetened beverages possibly contributed to
the increased calorie intake in those groups134.
Comment 4: The internal inconsistency of findings may warrant some more discussion for
example for fresh red meat and total red meat. It is relevant for the public to know if they
should be avoiding all red meat or only processed meat. Currently, total red meat receives a
high evidence rating but fresh red meat does not which raises questions for actual
recommended eating practices. Similarly, if caffeinated and decaffeinated coffee show
similar associations with diabetes risk how can the evidence for caffeine be just as strong?
Some discussion on the integration of key results would be useful.
Response: We thank Professor van Dam for raising this very important point. Accordingly,
we included this issue in our discussion.
Page 22, line 590ff: High quality of evidence was also observed for the positive association
between red meat, processed meat and bacon and incidence of T2D. In a recent pooled
analysis of fourteen studies, the consumption of processed meat and unprocessed red meat
was associated with higher fasting glucose and fasting insulin levels110, and some other
studies99 111 112, but not all110, have reported similar results as well as associations with CRP,
ferritin, HbA1C and GGT99 112. In some of these studies associations were attenuated when
adjusted for BMI99 111 112, which is consistent with the much stronger associations reported
between unprocessed and processed red meat intake and T2D in analyses unadjusted for
BMI than when adjusted for BMI39 113 114. Given that both unprocessed and processed red
meat has been associated with weight gain over time109 115 it is possible that increased weight
gain may be an important mechanism by which meat intake increases incidence of T2D.
Although the association with unprocessed red meat was not significant in the meta-analysis
from 201336 , this finding needs to be interpreted with caution as additional cohort studies
have since been published116-121 and most of the larger of these cohorts found an increased
risk also with unprocessed red meat116-119. Processed meat contains high amounts of
sodium, that may cause microvascular dysfunction and increase incidence of T2D122-124, as
well as nitrates, nitrites and their by-products, such as peroxynitrite, which seems to play a
role in the pathogenesis of T2D125.
Page 25, line 678ff: In terms of internal consistency, we observed, that related exposures
showed the same direction of the association with incidence of T2D. For example, a healthy
dietary pattern (characterized, amongst others, by a high intake of whole grain products and
low intake of red and processed meat), high consumption of whole-grain products, fibre and
16
magnesium were all associated with a reduced incidence of T2D. In accordance, an
unhealthy dietary pattern, high consumption of red meat, as well as processed meat (e.g.
bacon), animal protein and heme iron were related to an increased incidence of T2D.
However, as explained above, the role of unprocessed red meat regarding incidence of T2D
needs further investigation. Moreover, the results on caffeinated and decaffeinated coffee
and caffeine warrant further discussion. Both caffeinated and decaffeinated coffee were
associated with a decreased incidence of T2D, suggesting that caffeine does not play a
major role in the health effect of coffee. Nevertheless, caffeine was also observed to
decrease T2D incidence. All associations were graded as moderate quality of evidence.
While caffeine is discussed to have beneficial properties, e.g. increase insulin sensitivity145,
the results are hard to interpret because of the strong correlation with coffee consumption55.
Therefore, caffeine might act as a marker for coffee intake, which contains several beneficial
compounds, e.g. chlorogenic acid and antioxidants, that contribute to the reduction of T2D
incidence55. Since decaffeinated coffee showed a similar association with incidence of T2D
as caffeinated coffee, it seems plausible that these other bioactive compounds in coffee
mainly contribute to the reduction of T2D incidence with coffee consumption.
Comment 5: In the 'what does this study add section' the authors conclude that the effects of
diet on type 2 diabetes risk are moderate. It should be noted, however, that the Predimed
trial showed a 50% reduction in risk with only dietary changes. Whether effects of diet as a
whole are moderate or stronger may depend on the contrast of intakes that is examined in
studies and how many different aspects of the diet are targeted in combination.
Response: Thank you for this comment. To be more careful, we changed the statement in
this section. We also included the results from the Predimed trial in the discussion.
Page 31, line 832f: There is existing evidence that dietary factors play a role in the
development and prevention of T2D.
Page 26, line 698ff: In general, diet is a complex combination of foods and nutrients that act
synergistically146. In this umbrella review, dietary patterns were all associated with incidence
of T2D, but the quality of evidence for dietary patterns was moderate. To account for the full
spectrum of the association between diet and T2D, future studies could investigate a dietary
score, including all important aspects of a healthy diet that have been identified to play a role
in the risk of T2D. This approach might be more predictive of T2D risk than the investigation
of single foods and nutrients146. For example, a strong reduced risk of T2D (reduction by
17
52%; 95% CI: 14%, 73%) was identified for the adherence to the Mediterranean diet
(supplemented with either extra virgin olive oil or mixed nuts) compared to a control diet
(advice to reduce only dietary fat) in the PREDIMED trial147. Thus, to give accurate
recommendations regarding diabetes prevention, it is important to identify the optimal diet(s).
Comment 6: The authors should be careful about the similarity in units of exposure when
they are comparing the strength of associations for different dietary factors. For example, the
units for hamburger vs bacon intake are rather different.
Response: We thank Professor van Dam for raising our attention to this lack of clarity. We
think it might add to the confusion, that we’ve given the range of summary hazard ratios in
the result section, since this might look like a direct comparison of the strengths of
associations. We therefore removed these from the text.
Specific comments
Comment 7: Abstract results: the authors present the percentage of dietary factors that were
directly, inversely, or not associated with T2D. The authors should make clear that these are
not inconsistent results, but are different results for different aspects of the diet.
Response: Thank you for pointing this out. We adapted the sentence accordingly.
Page 2, line 46ff: Of these meta-analyses of different dietary factors, 31% reported a
decreased incidence, 16% an increased risk incidence and 53% found no association
between diet and risk incidence of T2D.
Comment 8: Avoid terms such as ‘increased risk’ or ‘decreased risk’ as you are focusing only
on observational studied comparing risk for different groups of individuals rather that
changes in risk in individuals.
Response: Thank you for making this point. We changed „increased risk“ and „decreased
risk“ to „increased incidence“ and „decreased incidence“ throughout the manuscript.
Comment 9: The authors should explicitly discuss what level of evidence they believe is
sufficient to support dietary recommendations and discuss their findings for different dietary
factors accordingly. I am surprised they state that their findings support recommendations for
a Low glycemic index diet, whereas their evidence classification for this is ‘Low’.
18
Response: This is an interesting point. The statement regarding low GI was corrected. In
order to systematically discuss the most important findings, we particularly focused on the
findings with high quality of evidence, as we did in our abstract. We specified this in the
discussion section.
Page 19, line 496ff: Though intake of foods with a high GI were associated with an increased
risk incidence of T2D in our umbrella review, quality of evidence was only low and further
studies should investigate if this recommendation can be supported.
Page 21, line 565f: In the next section, further potential mechanisms for the observed
associations with high quality of evidence will be discussed.
Comment 10: The authors state or imply in the discussion section that whole grains are low
in glycemic index (GI) and sugar sweetened beverages and sucrose are high in GI. Please
note that whole grains can both be high or Low in glycemic index so this does not reflect the
same dimension of the diet. Similarly, sucrose or high fructose corn syrup have an
intermediate GI as the fructose component has a Low GI.
Response: Thank you, this is a very good point. We deleted the comparison for whole grain
and sucrose (page 22, line 587ff) and specified examples for sugar sweetened beverages.
Page 23, line 615ff: SSB, such as sugar-containing lemonades, can have high GI131, which is
related to an increase in blood sugar levels and associated with increased incidence of
T2D107 108. However, beverages high in fructose or isomaltulose, which is a slowly absorbable
disaccharide used in sports drinks, have a lower GI132. An RCT compared two intervention
groups consuming 20% of their energy requirement in form of beverages sweetened with
isomaltulose (low GI) and maltodextrin (high GI). The insulin response was lower and insulin
sensitivity better preserved in the group consuming beverages with low GI compared to the
group consuming beverages with high GI132.
Comment 11: The authors mention the fact that high quality evidence evidence was
observed for only 5% of examined dietary factors as a study limitation. Why would that be a
limitation of this study?
Response: Thank you for making this point. We eliminated this point from the limitations
section.
19
Reviewer 4, Doctor Patricia Metcalf
Comments:
Comment 1: Some of the information presented is useful, but there is too much information
which results in the manuscript being too overwhelming and losing the interest of the reader.
The manuscript needs to be shortened if it is to retain the interest of the reader. Perhaps the
manuscript should just focus on the high quality of evidence nutrients/foods.
This is an extremely long article comprising 30 pages before the Tables and 141 pages with
Figures, Tables and Supplementary material. Table 1 is 11 pages long. Most of the
paragraphs are very long. Because of the length of the manuscript, it becomes tedious.
Response: We thank Doctor Metcalf for making this point. We excluded Supplementary
Tables 3-20, which shortened the supplement by 53 pages. Supplementary Tables 3-6
contained extracted data (e.g. study characteristics and results) of the meta-analyses
included in our umbrella review. Supplementary Tables 8-20 included the same information
for all identified meta-analyses regarding dietary factors and incidence of type 2 diabetes,
including duplicate meta-analyses on the same topic. To exclude duplicate data and to avoid
confusion regarding extracted and recalculated results, we excluded these tables. We further
moved Table 1 from the manuscript to the supplement (now Supplementary Table 3), which
shortened the manuscript by 11 pages. This table provides information on the characteristics
of the included meta-analyses and results of the recalculation.
Comment 2: There is quite a lot of repetition of words in the results section. The manuscript
would be enhanced by concentrating on a briefer list of foods/nutrients, rather than including
them all. For example, breast feeding is probably not necessary, nor are most of the
micronutrients. The Supplementary Figures could be plotted with more Figures on a page to
shorten the manuscript.
Response: Thank you for this comment. We believe it is a strength of our umbrella review
that it provides such a comprehensive overview of any existing evidence regarding dietary
factors and incidence of T2D, especially since there is such a large body of research
available. By giving such a broad overview and by evaluating the quality of evidence, internal
consistencies or inconsistencies can be examined and relevant research directions can be
identified.
However, we made an effort to shorten the manuscript, as described in comment 1.
Additionally, instead of showing results from both high vs low and dose-response analyses in
20
the results and (Supplementary) Tables and Figures, we excluded the high vs low analysis
where a dose-response analysis was available. According to Doctor Metcalf’s suggestion, we
excluded the meta-analysis on ‘being breastfed‘ and incidence of type 2 diabetes. In addition,
since the editor and some of the reviewers suggested to exclude meta-analyses of RCTs, the
exposures selenium and niacin have been excluded from our report. Finally, to shorten the
manuscript, we plotted more Supplementary Figures on one page.
Page 10, line 256ff: These 153 SHRs correspond to one meta-analysis per exposure. If a
high vs low as well as a dose-response analysis was available for one exposure, we present
the dose-response analysis.
Comment 3: Most of the associations are relatively small. Where summary relative risks are
calculated for an increase in serving size, these serving sizes seem to be rather large,
emphasizing that the original relative risks were very small.
Response: Thank you for raising this point. Since it was beyond the scope of this umbrella
review to conduct our own dose-response meta-analyses, we resumed the doses from the
published meta-analyses. They were not standardized and the doses have to be considered
when interpreting the results. We added this point to our limitations section.
Page 27, line 722ff: In this context, it also has to be noted that we resumed the doses
defined in the published meta-analyses. Therefore, they are not standardized and the doses
have to be considered when interpreting the results. For example, the serving sizes defined
for total sugars, sucrose and fructose were rather large and the summary risk estimate might
be smaller when choosing a smaller serving size.
Comment 4: Some sentences are difficult to understand as they do not conform to traditional
English rules. There are some grammatical errors. Sentences should not begin with a
numerical number. The number written as a word is acceptable. 'Vegetable' not 'Vegatable'
on page 41.
Response: We thank you for raising our attention to this and apologize. We re-read the
manuscript carefully and corrected errors wherever we found them. We changed number in
the beginning of sentences to written words and corrected typeos wherever we found them.
Reviewer 5, Doctor Ulrika Ericson
21
Comments:
Comment 1: A problem might be that all criteria included in Nutrigrade contributes 0-1 points,
except the bias/study quality/ study limitations, although they may be more or less important.
This could be brought up in the discussion.
Response: We thank Doctor Ericson for raising this point, which we added to our limitations.
Page 29, line 790ff: Eight, in the NutriGrade tool all criteria contribute to the overall score
with one point, except for bias/study quality/study limitations as well as effect size which
contribute with two points. Therefore they receive more weight. However, bias/study
quality/study limitations includes several aspects, such as assessment of exposure and
outcome and confounding, which may justify a higher weight.
Comment 2: Page 21, line 38-43. In the conclusion, it is stated that future studies should
focus on less frequently investigated dietary exposures for which there is low quality
evidence for associations. However, I mean that it is important to focus on factors for which
there are plausible biological hypothesis and maybe not on single food items such as
sherbet, despite the low quality evidence. In line with this, I suggest that the conclusion is
somewhat changed in order to highlight that some exposures are more important to examine
than others.
Response: Thank you for this comment. We agree that this is an important distinction and
that our conclusions in that matter need to be more specific. We therefore adapted our
conclusions accordingly.
Page 30, line 809ff: Moreover, future studies should focus on exposures, which are
biologically likely to be associated with incidence of T2D, but for which quality of evidence is
still low. Additionally, since recommendations are based on foods and food groups, future
studies should focus on answering open questions in terms of internal inconsistencies, such
as the role of unprocessed meat and processed red meat in the harmful association of total
meat and red meat with incidence of T2D. In that context, more research is also needed on
specific foods for which evidence is still low, such as types of rice (white rice, brown rice),
types of fish (oily or lean fish) or types of fat (e.g. olive oil).
Comment 3: The importance of dietary data of high validity in future studies should be
stressed, because some true associations may not have been observed as some exposures
may be more difficult to measure than others, e.g. due to issues related to misreporting.
22
Response: We thank Doctor Ericson for making this important point. We stressed this issue
in our conclusions.
Page 30, line 807ff: It is important to attain dietary data with high validity by improving dietary
measurement methods and by assessing and accounting for changes in dietary behaviour
over time
Comment 4: Figure numbers are missing for Figures 1-3b
Response: We added the Figure numbers.
Comment 5: Page 14, Line 42: Replace in Table 4 by in Table 2?
Response: Thank you. We corrected the Table number.
Comment 6: It would be valuable to identify some specific dietary exposes that would be
especially important to examine, instead of only mentioning that less frequenltly examined
factors or factors for which the evidence is graded as low should be examined.
Response: We agree that our conclusions need to be more specific. Please see comment 2
for changes made in the manuscript.
Comment 7: Table 2: “Evidence” could be replaced by “Quality of evidence”
Response: We adapted the title of the column in Table 2 accordingly.
Reviewer 6, Professor Richard Riley
Comment 1: I must admit that I am circumspect of many nutritional epidemiology studies, as
often it is hard to identify exactly the type of food/diet under review and exactly if/how this is
related to outcome risk. I think similar concerns arise in this overview, as by taking an
umbrella overview of all diet studies in this field, the scale is very broad and it is hard to
identify specific implications for what diet is beneficial. For example, in the abstract the main
conclusions relate to food/drink such as sugary sweetened beverages, processed meat, and
red meat. But these are very broad groups – e.g. what specific sweetened beverages are we
talking about? What specific processed meat? E.g. in their discussion they say: “In
23
accordance, an unhealthy dietary pattern, high consumption of red meat, especially
processed meat (e.g. bacon, hamburgers or hot dogs), animal protein and heme iron were
related to an increased risk of T2D.” – but is it bacon or a hot dog I should be avoiding?
I find that focussing recommendations on a broad class is difficult to interpret. Of course, this
is a consequence of the authors summarising the existing evidence – so I am not criticising
the authors themselves, as they can only summarise what is reported. But I do worry about
the translation of the findings for the BMJ reader, and that the press may pick up on some
broad (non-specific) message.
Response: We thank Professor Riley for making this important point. We agree that it is very
important to give precise recommendations. Therefore we believe it is a strength of our
umbrella review that it provides such a comprehensive overview of the evidence regarding
dietary factors, including specific foods and subgroups, and incidence of type 2 diabetes. We
identified evidence on food subgroups for example for total dairy (e.g. low-fat, high-fat dairy
products), total grains (whole grain, refined grain), rice (white rice, brown rice), total meat
(red meat, processed meat, processed red meat, unprocessed red meat), fish (e.g. lean fish,
oily fish), total vegetables (green leafy vegetables, cruciferous vegetables, yellow
vegetables), total fruit (berries, citrus fruits, apples and pears), coffee (caffeinated,
decaffeinated, caffeine), total fruit juice (fruit juices with and without added sugar) and total
alcohol (beer, wine, spirits), as well as for specific foods for example milk (total, high-fat and
low-fat), yogurt, cheese, whole grain bread, whole grain cereals, bacon, hamburgers and hot
dogs. Sugar-sweetened beverages include sugar-sweetened carbonated lemonades and
fruit-flavoured carbonated sugar soft drinks. However, for specific drinks no evidence was
available. By giving such a broad overview and by evaluating the quality of evidence, internal
consistencies or inconsistencies can be examined and relevant research directions can be
identified. In our abstract we emphasize results with high quality of evidence. For specific
foods and food subgroups, however, the quality of evidence is low or very low and more
research is needed for specific recommendations to be made. We added this to our
discussion and conclusion.
Discussion: Page 22, line 590ff: High quality of evidence was also observed for the positive
association between red meat, processed meat and bacon and incidence of T2D. In a recent
pooled analysis of fourteen studies, the consumption of processed meat and unprocessed
red meat was associated with higher fasting glucose and fasting insulin levels110, and some
other studies99 111 112, but not all110, have reported similar results as well as associations with
CRP, ferritin, HbA1C and GGT99 112. In some of these studies associations were attenuated
24
when adjusted for BMI99 111 112, which is consistent with the much stronger associations
reported between unprocessed and processed red meat intake and T2D in analyses
unadjusted for BMI than when adjusted for BMI39 113 114. Given that both unprocessed and
processed red meat has been associated with weight gain over time109 115 it is possible that
increased weight gain may be an important mechanism by which meat intake increases
incidence of T2D. Although the association with unprocessed red meat was not significant in
the meta-analysis from 201336 , this finding needs to be interpreted with caution as additional
cohort studies have since been published116-121 and most of the larger of these cohorts found
an increased risk also with unprocessed red meat116-119. Processed meat contains high
amounts of sodium, that may cause microvascular dysfunction and increase incidence of
T2D122-124, as well as nitrates, nitrites and their by-products, such as peroxynitrite, which
seems to play a role in the pathogenesis of T2D125.
Discussion: Page 25, line 678ff: In terms of internal consistency, we observed, that related
exposures showed the same direction of the association with incidence of T2D. For example,
a healthy dietary pattern (characterized, amongst others, by a high intake of whole grain
products and low intake of red and processed meat), high consumption of whole-grain
products, fibre and magnesium were all associated with a reduced incidence of T2D. In
accordance, an unhealthy dietary pattern, high consumption of red meat, as well as
processed meat (e.g. bacon), animal protein and heme iron were related to an increased
incidence of T2D. However, as explained above, the role of unprocessed red meat regarding
incidence of T2D needs further investigation. Moreover, the results on caffeinated and
decaffeinated coffee and caffeine warrant further discussion. Both caffeinated and
decaffeinated coffee were associated with a decreased incidence of T2D, suggesting that
caffeine does not play a major role in the health effect of coffee. Nevertheless, caffeine was
also observed to decrease T2D incidence. All associations were graded as moderate quality
of evidence. While caffeine is discussed to have beneficial properties, e.g. increase insulin
sensitivity145, the results are hard to interpret because of the strong correlation with coffee
consumption55. Therefore, caffeine might act as a marker for coffee intake, which contains
several beneficial compounds, e.g. chlorogenic acid and antioxidants, that contribute to the
reduction of T2D incidence55. Since decaffeinated coffee showed a similar association with
incidence of T2D as caffeinated coffee, it seems plausible that these other bioactive
compounds in coffee mainly contribute to the reduction of T2D incidence with coffee
consumption.
Conclusion: Page 30, line 811ff: Additionally, since recommendations are based on foods
and food groups, future studies should focus on answering open questions in terms of
25
internal inconsistencies, such as the role of unprocessed meat and processed red meat in
the harmful association of total meat and red meat with incidence of T2D. In that context,
more research is also needed on specific foods for which evidence is still low, such as types
of rice (white rice, brown rice), types of fish (oily or lean fish) or types of fat (e.g. olive oil).
Comment 2: Another reason for concern is the difficulty in adjusting for confounders, as the
findings are all based on primary studies that were observational. As the focus in the review
is at the broad umbrella review level, I do find it quite detached from the original primary
studies. In particular, what adjustment factors were used in each primary study? Were they
adequate? What methods were used to adjust for confounding in primary studies and were
they suitable? Is a linear dose response relationship truly justified? Indeed, was this even
checked in the original studies, let alone at this umbrella review stage? These are just some
examples of why I find the review rather detached from the original primary studies, and thus
it is hard to ascertain whether the findings are meaningful.
Response: Professor Riley is correct. The primary studies, which were included in the meta-
analyses and thus, in our umbrella review had all a prospective observational study design.
To account for the influence of potential confounding regarding the association between
dietary factors and incidence of T2D, we excluded primary studies showing only crude
estimates. Almost all of the primary studies (90%) adjusted for age and sex. Further
important potential confounders were considered in most of the studies: 87% adjusted for
smoking status, 86% for BMI and physical activity. Two thirds of the studies also adjusted for
further dietary factors, including total energy intake (67%), alcohol intake (65%), or other
dietary factors (60%). Half of the studies (52%) adjusted for family history of diabetes. The
corresponding risk ratios with their 95% CI were calculated by using multivariable Cox
proportional hazard regression models in 80% of the studies and multivariable logistic
regression model in the remaining 20%. We added more detailed information about the
adjustment factors and methods. In addition, our limitation section includes a statement
about residual confounding.
Since it was beyond the scope of this umbrella review to conduct our own dose-response
meta-analyses, we recalculated them if the dose-response estimate for each primary study
was presented separately. If this information was missing, we could not recalculate the dose-
response meta-analysis, but extracted the SHRs from the published meta-analysis.
Information on linearity of the dose-response relations were available for 72% of the dose-
response analyses. For one third of these dose-response relations there was indication for
non-linearity (potential renal acid load (PRAL), yogurt, ice cream, chocolate, processed meat,
26
olive oil, whole grain, total grains, whole grain bread, whole grain cereals, wheat bran, brown
rice, total fruit, apples and pear, total vegetables, cereal fibre, fruit fibre, vegetable fibre,
magnesium and anthocyanins). To derive recommendations, further investigation is needed
to set optimal cut-points. We added this to our results and limitations.
Methods: Page 9, line 224ff: If the published meta-analysis included a primary study only
reporting crude estimates, this study was excluded from our re-analysis.
Results: Page 12, line 295ff: All included primary studies conducted multivariable adjustment
using regression models (80% Cox proportional hazard regression model, 20% multivariable
logistic regression). Almost all of the primary studies (90%) adjusted for age and sex, 87%
for smoking, 86% for BMI and physical activity, respectively, 67% for total energy intake,
65% for alcohol intake, 60% for other dietary factors or cardiovascular risk factors (e.g.
Hypertension), respectively, and 52% for family history of diabetes.
Discussion: Page 27, line 738ff: Nevertheless, the most important confounders were
adjusted for in most of the primary studies (90% for age and sex, 87% for smoking, 86% for
BMI and physical activity, respectively. However, residual confounding cannot be completely
ruled out. For example, only half of the studies (52%) adjusted for family history of diabetes,
which should be included in the adjustment model of future studies.
Results: Page 12, line 303ff: Information on linearity of the dose-response relations were
available for 72% of the dose-response analyses. For one third of these dose-response
relations there was indication for non-linearity (PRAL, yogurt, ice cream, chocolate,
processed meat, olive oil, whole grain, total grains, whole grain bread, whole grain cereals,
wheat bran, brown rice, total fruit, apples and pear, total vegetables, cereal fibre, fruit fibre,
vegetable fibre, magnesium and anthocyanins).
Discussion: Page 27, line 727ff: Additionally, information on linearity of the dose-response
relations were available for 72% of the dose-response analyses. For one third of these dose-
response relations there was indication for non-linearity. To derive recommendations, further
investigation is needed to set optimal cut-points.
Comment 3: In regards to the adjustment factors, the authors say: “Almost all of the primary
studies adjusted at least for age and sex, with the exception of four primary studies which
reported crude estimates.” – surely these 4 studies should be removed? Further, “ 80% of
the primary studies conducted a multivariate adjustment (e.g. for total energy, body mass
27
index, smoking status and physical activity).” – yes, but were the adjustment factors
adequate? It would perhaps have been clearer had the authors pre-specified a set of
adjustment factors that were considered essential (minimum required), in order to have some
credence that the adjusted results were only prone to small residual confounding.
Response: We thank Professor Riley for raising this point. To account for the influence of
potential confounders regarding the association between dietary factors and incidence of
T2D, we excluded primary studies showing only crude estimates. In the investigation of
dietary factors and T2D, the most important confounders include age, sex, other lifestyle
factors (such as smoking, physical activity), overweight, total energy, other dietary factors,
alcohol intake, and family history of diabetes. We checked all primary studies (n=277) which
confounders were included in their statistical analysis and added this in more detail to our
results and discussion section. Moreover, the level of adjustment was also considered in the
assessment of the quality of the evidence by using NutriGrade. The first item focuses on
(amongst others) the inclusion of potential confounders (Item 1: Risk of bias/ study quality/
study limitations).
Methods: Page 9, line 224ff: If the published meta-analysis included a primary study only
reporting crude estimates, this study was excluded from our re-analysis.
Results: Page 12, line 301ff: Three primary studies only reported crude estimates and where
therefore excluded from the meta-analyses on milk81, total coffee81 and total alcohol82 83. This
did not affect the results.
Results: Page 12, line 297ff: Almost all of the primary studies (90%) adjusted for age and
sex, 87% for smoking, 86% for BMI and physical activity, respectively, 67% for total energy
intake, 65% for alcohol intake, 60% for other dietary factors or cardiovascular risk factors
(e.g. Hypertension), respectively, and 52% for family history of diabetes.
Discussion: Page 27, line 738ff: Nevertheless, the most important confounders were
adjusted for in most of the primary studies (90% for age and sex, 87% for smoking, 86% for
BMI and physical activity, respectively. However, residual confounding cannot be completely
ruled out. For example, only half of the studies (52%) adjusted for family history of diabetes,
which should be included in the adjustment model of future studies.
Comment 4: Related point: in the discussion it says “It is likely that individuals with unhealthy
dietary behaviours, such as low intake of whole grains and fibre, as well as higher intake of
28
red and processed meat, have an unhealthier lifestyle per se, such as higher rates of obesity,
smoking and physical inactivity83-85. Most of the included studies adjusted for these factors,
and associations persisted” – the word ‘most’ is not reassuring to me, but moreover the
question remains as to whether the adjustment of these factors (when done) was actually
adequate. Was a regression approach used without backwards/forwards selection of
adjustment variables? Or perhaps a propensity score analysis was done – but was it done
well? Etc.
Response: According to this comment, we went back to all primary studies (n=277), and
checked the methods of adjustment and the confounders which were included in the primary
studies. As described above (comment 3), we predefined a set of important confounders and
checked all primary studies which confounders were included in their statistical analysis. In
addition, 80% of these studies used multivariable Cox proportional hazard regression models
and the remaining 20% multivariable logistic regression model. No further approach has
been applied.
We added this information to the methods section and the mentioned part in the discussion.
Methods: Page 7, line 168ff: For each primary study included in the published meta-analysis
we extracted [S] as well as the adjustment factors included in the model to check if relevant
confounders were accounted for. Based on the literature, the most important potential
confounders in the investigation between dietary factors and incidence of T2D include age,
sex, smoking, physical activity, overweight, other dietary factors, including total energy
intake, alcohol intake, and family history of diabetes.
Discussion: Page 21, line 557ff: However, 87% of the included primary studies adjusted for
smoking and 86% for BMI and physical activity, respectively, in multivariable regression
models and the associations persisted. Nevertheless, residual confounding cannot be ruled
out, [S].
Comment 5: Multivariate adjustment should say multivariable adjustment
Response: We apologize for the mistake and adapted it in the manuscript.
Comment 6: I find the data extraction description confusing in the methods. E.g. “If the RR
estimates from primary studies of a dose-response meta-analysis were not reported in the
published meta-analysis, we did not recalculate the meta-analysis, but extracted the SRR
from the published meta-analysis. If we could not identify a RR estimate from a primary study
29
of a high vs. low meta-analysis in the published meta-analysis or the primary study itself, we
excluded that particular primary study from our meta-analysis.” – please re-write this in
clearer language for the BMJ reader to follow.
Response: Thank you for this comment. We re-wrote the sentences to be clearer.
Page 9, line 226ff: We recalculated dose-response meta-analyses if the dose-response
estimate for each primary study was presented separately. If this information was missing,
we could not recalculate the dose-response meta-analysis, but extracted the SHRs from the
published meta-analysis.
Comment 7: I might be wrong, but it appears to me that the authors are pooling meta-
analysis results. Why not actually take the original primary study results, and pool these in a
single meta-analysis? I do not see why pooling the original meta-analysis results is more
helpful. Please can they justify this. Also, does this not then make the heterogeneity a
between-meta-analysis heterogeneity? Rather than a between-study heterogeneity? If so,
this is hard to interpret.
Response: We apologize for the misunderstanding about the level of data pooling. We did
not pool meta-analysis results. For each exposure we chose the one meta-analysis that
included the largest numbers of studies and study participants, which was usually the most
recent one. Our umbrella review was conducted as it has been done in the past (e.g. Poole
BMJ 2017, PMID: 29167102; Kalliala BMJ 2017, PMID: 29074629; Kyrgiou BMJ 2017,
PMID: 28246088; Tsilidis BMJ 2015, PMID: 25555821). We recalculated the existing meta-
analyses to make sure that the calculations were done by the same random effects model,
and to receive further information for the evaluation of the quality of evidence, including tau²,
prediction intervals, I², publication bias etc. For clarification, we have revised the contents of
description of the methods, including the study design.
Introduction: Page 4, line 91ff: Umbrella reviews are very useful tools in research that provide
a comprehensive overview of evidence of published systematic reviews and meta-analyses
on a specific topic. They are helpful to elucidate the strength of evidence and the precision of
the estimates and evaluate risk of bias of the published reports8.
Methods: Page 6, line 153ff: If more than one published meta-analysis on the same
association was identified, we chose only one meta-analysis for each exposure to avoid the
inclusion of duplicate studies.
30
Methods: Page 9, line 211ff: For each exposure the meta-analysis was recalculated using
the maximally adjusted hazard ratios of the primary studies included in the published meta-
analyses. To assure that all summary hazard ratios (SHRs) were calculated by using a
random effects model and to receive further information for the evaluation of the quality of
evidence, including tau² (τ2), 95%-prediction intervals (95%-PIs), I² and publication bias, we
recalculated the SRRs SHRs and their corresponding 95%-CIs by using the random effects
model by DerSimonian and Laird, which takes into account both within and between study
heterogeneity18.
Comment 8: It also appears that the meta-analysis results bare eing pooled ignoring the
uncertainty in heterogeneity estimates (within a meta-analysis and across meta-analyses).
This would be easier to address if pooling all the study-specific results in one go. See
references such as Cornell et al. and the use of methods such as the hartung Knapp method
for widening confidence intervals Cornell JE, Mulrow CD, Localio R, et al. Random-effects
meta-analysis of inconsistent effects: a time for change. Ann Intern Med 2014;160(4):267-70.
Hartung J, Knapp G. A refined method for the meta-analysis of controlled clinical trials with
binary outcome. Stat Med 2001;20(24):3875-89.
Response: Thank you for raising this very interesting point. As stated earlier, we pooled
findings from primary studies and not estimates from different meta-analysis. We decided to
apply random effects model by DerSimonian and Laird, which takes into account both within
and between study heterogeneity. Since, this method has been used in previous meta-
analyses, we chose this approach, to ensure comparability with the published meta-
analyses.
Page 9, line 213ff: To assure that all summary hazard ratios (SHRs) were calculated by
using a random effects model and to receive further information for the evaluation of the
quality of evidence, including tau² (τ2), 95%-prediction intervals (95%-PIs), I² and publication
bias, we recalculated the SHRs and their corresponding 95%-CIs by using the random
effects model by DerSimonian and Laird, which takes into account both within and between
study heterogeneity18. Since, this method has been used in previous meta-analyses, we
chose this approach, to ensure comparability with the published meta-analyses.
Comment 9: Heterogeneity should not be measured by I2, and it is wrong to use values of I2
to define low, moderate or high heterogeneity. Better to report estimate of the heterogeneity
itself (tau-squared) and, possible, prediction intervals to disseminate the heterogeneity.
31
Rucker G, Schwarzer G, Carpenter JR, et al. Undue reliance on I(2) in assessing
heterogeneity may mislead. BMC Med Res Methodol 2008;8:79.
Response: We thank Professor Riley for making this point. We do not define heterogeneity
by categorization of I² anymore. We additionally calculated tau2 and 95% prediction intervals
as recommended. In addition, after discussion with our director of the institute (Professor
Oliver Kuß, Biometrician), we decided to include the dispersion around the SHR by
calculating the interval where 95% of the primary HRs lie within (two-sigma rule: θ�± 2τ) to
provide further information about heterogeneity. We have added the related information in
the methods and the results section and in Supplementary Table 3.
Methods: Page 9, line 237ff: Heterogeneity was evaluated by using the I2 statistics. The I2
value ranges from 0% to 100% and represents the percentage of the total variation across
studies that can be explained by heterogeneity19. However, I2 is dependent on the study size
(it increases with increasing study size). Therefore, we additionally calculated τ2, which is
independent of the study size and describes between study-variability of the risk estimate20.
In addition, we used the two-sigma rule (θ�± 2τ) to calculate the interval where 95% of the
primary HRs lie within to further evaluate the dispersion around the SHR. Finally, we
calculated 95%-prediction intervals (95%-PIs) which further account for heterogeneity and
show the range in which the effect estimates of future studies will lie with 95% certainty21.
Results: Page 15, line 401ff: I², τ 2, dispersion around the SHRs and 95%-PIs are reported in
Supplementary Table 3. For 23% and 29% of the meta-analyses τ2 and the 95%- PIs could
not be recalculated. As for the 95-% PIs, only 5% of the meta-analyses excluded the null-
value, namely the high vs low analyses of healthy dietary pattern, unhealthy dietary pattern
and breakfast skipping and the dose-response analyses of apples and pears, total coffee,
artificially sweetened beverages, light, moderate and high wine intake and magnesium. That
indicates that it is expected that findings in future studies on these exposure will point to the
same directions. However, for the majority of the findings, it is likely that the estimate
obtained in a future primary study might result in a null finding.
Comment 10: Funnel plot asymmetry does not imply publication bias; a better word is
small=study effects, which indeed may be due to pub bias, but might also be due to other
things.
Response: Thank you for this remark. We changed the terms accordingly.
32
Page 16, line 432f: When we explored the funnel plots (Supplementary Figures 2-19), there
was indication for small study effects for [S]
Comment 11: The authors report relative risks. But are the studies really reporting hazard
ratios? And if not, then what are the time-points of interest for diabetes onset, as the RRs are
time-specific measures. This is a critical issue, because I do not see justification for why
relative risks are useful in this context and not hazard ratios. ? If they are hazard ratios, then
really are these constant over time? Was this checked in the original studies? Another
example, perhaps, of being too detached from original studies.
Response: Professor Riley is absolutely right, most of the primary studies (80%) reported on
hazard ratios using the cox proportional hazard regression model. The remaining 20%
calculated relative risk by applying logistic regression models. All of the studies included had
a prospective study design, and participants were free of type 2 diabetes at baseline.
According to this comment, we changed the term summary relative risk (SRR) to summary
hazard ratio (SHR) in the manuscript.
Comment 12: What does this mean: “For most of the associations, there was no indication
for presence of publication bias according to Egger’s test (p≥0.10), with the exception of
chocolate, whole grain, wheat germ, rice, white rice, soy products, legumes, hot dogs, animal
protein, monounsaturated fatty acids, total carbohydrates, total fibre, vitamin D, total iron in
high vs. low meta-analyses, as well as total dairy, low-fat milk, coffee and cereal fibre from
dose-response meta-analyses (Table 1).” – the authors imply no publication bias, and then
list many areas where there may be. I find this confusing.
Response: Thank you for raising our attention to this lack of clarity. We adapted the sentence
accordingly.
Page 16, line 424ff: There was indication for presence of publication bias according to
Egger’s test (p≥0.10) for [S] rice, [S].
Comment 13: Is it justified to mix cohort and case control studies? Moreover, it seems that
‘cross-sectional’ studies are also included. But surely we need a design with a time-to-event
outcome, to at least have reassurance that the diet recording was made at a point before the
onset of diabetes. More explanation is needed in these matters.
33
Response: We apologize that it does not become clear from our manuscript. We only
included prospective cohort studies in the meta-analyses.
Page 6, line 131f: Studies were included if they met the following criteria: (1) Meta-analysis of
observational prospective cohort studies [S]
Page 9, line 222ff: If the published meta-analysis included retrospective case-control studies
or cross-sectional studies as well as prospective cohort studies, we only included results
from the prospective cohort studies in our meta-analysis.
Comment 14: “the quality of evidence by applying the NutriGrade scoring system, which
comprises different sources of bias (including funding), study design, heterogeneity between
studies, the effect size and its precision.” – I do not see why the effect size and its precision
should be used to define quality. A more precise estimate does not imply higher quality.
Indeed a good quality study should be defined independent to any effect size estimate and
any magnitude of precision. Yes, bias may impact these things, but the actual decision about
quality should be based on the information about the factors that cause it.
Response: Thank you for this comment. The quality of evidence provides information about
the level of confidence that can be put in a summary effect estimate, which was calculated by
meta-analysis. According to quality of evidence assessment tools like GRADE and
NutriGrade, both effect size and precision are indicators for certainty or uncertainty of such a
result. The magnitude of the effect is included under the general assumption that very large
effects are less likely driven by confounding (Guyatt et al, Grade guidelines 9, J Clin
Epidemiol, 2011). In GRADE, a large effect (RR >2 or <0.5) in observational studies scores
one more point and a very large effect (RR >5 or <0.2) two more points (GRADE handbook,
2013). Since such very large effects are unlikely in nutritional research, the scoring
procedure was adapted in NutriGrade (Schwingshackl et al, Advances of Nutrition, 2016).
Imprecision is considered an important factor when evaluating the quality of evidence, since
wide confidence intervals are usually seen in small studies and raise uncertainty about the
findings (GRADE handbook, 2013). On the other hand, precise estimates raise confidence in
a result (Guyatt et al, Grade guidelines 6, J Clin Epidemiol, 2011).
Comment 15: In regards to evaluating quality, I also found it confusing that the overall quality
assessment is made at the meta-analysis level (i.e. each meta-analysis included in the
umbrella review), and not at the study-specific level. If the authors rather pool the original
34
studies, rather than the meta-analysis results, should the quality assessment be made at the
study-specific level? They could even remove primary studies that were at high risk of bias,
which would otherwise still be included in the meta-analysis feeding into the umbrella review.
Response: We thank Professor Riley for raising this point. An umbrella review provides an
overview of meta-analyses, thus giving an overview of meta-evidence. Therefore, it is of
interest to evaluate the quality of this meta-evidence especially regarding their possible use
as basis for public health recommendations. This evaluation provides information on the level
of confidence that can be put into the summary risk estimates and if they are robust or likely
to change with future research. We agree that the quality of evidence of a meta-analysis
depends on the quality of primary studies. However, this aspect is included in NutriGrade
(Item 1: Risk of bias/ study quality/ study limitations) and therefore accounted for in the
overall quality of evidence provided in this umbrella review.
It was beyond the scope of this umbrella review to conduct or report subgroup and sensitivity
analyses. We added this to our limitations.
Page 8, line 189ff: The quality of evidence was evaluated by using a modified version of
NutriGrade17 (modifications are described in Supplementary Table 5). It is a numerical
scoring system (max. 10 points), which includes eight items: Risk of bias/ study quality/ study
limitations (mean of all primary studies included in the published meta-analysis) (0-2 points)
[S].
Page 28, line 748ff: Third, we did not explore subgroup analysis (e.g. by sex, geographic
locations, adjustment factors like BMI) or sensitivity analysis (e.g. exclusion of studies at high
risk of bias).
Comment 16: Is publication bias examined at the study-level or the meta-analysis level. That
is, are multiple primary study-specific estimates plotted on the funnel, or the multiple meta-
analysis results per diet type presented on the funnel plot. Again, I find it hard to ascertain
the level of the pooling. I think it is the primary study level.
Response: We thank the reviewer for this comment and apologize for the lack of clarity.
Publication bias was assessed at study-level. Therefore study-specific estimates are plotted
in the funnel.
As described in comment 7 the methods section is now clearer described regarding this
point. Additionally, we adapted the description of Supplementary Figures 2-20 accordingly.
35
Page 10, line 249ff: Publication bias and small study effects were assessed for each meta-
analysis by using graphical and statistical tests, namely the funnel plot and Egger’s test22 23.
Therefore, the primary studies from the meta-analyses included in our umbrella review, were
plotted.
For example Supplementary Page 28: Supplementary Figure 4: Funnel plots for the
association between A) eggs (dose-response) and incidence of type 2 diabetes. For each
meta-analysis the study-specific estimates were plotted in the funnel.